知镜 Cognispect · 医学文献与研究工作台

Preclinical innovations and translational opportunities of non-opioid analgesics for Neuropathic pain: a narrative review.

Sharma S, Rana P, Dhingra N, Kaur T.
Expert opinion on drug discovery · 2026-11-13 · PMID 43031365

文献摘要

Introduction Neuropathic pain represents a difficult-to-treat chronic pain condition associated with complex molecular mechanisms and clinical heterogeneity. Although many pharmacologic treatments are available, current therapies often fail to deliver adequate analgesia. They are burdened with dose-limiting side effects, pointing to the need for more tolerable and efficacious non-opioid therapies. Areas covered This review presents recent advances in non-opioid analgesic development for neuropathic pain, focusing on emerging molecular targets, including ion channels and neuroimmune signaling, and innovative drug discovery approaches. Google Scholar was searched for relevant literature between 14 June 2026 and 19 October 2026. The review also discusses emerging therapeutic agents, translational challenges, and future directions in precision medicine and biomarker-guided drug development. Expert opinion While significant progress has been achieved in discovering new non-opioid therapeutic targets, clinical translation remains challenging because of high disease heterogeneity, low predictive value of traditional preclinical models, lack of biomarker implementation, and insufficient target validation. Future success will depend on prioritizing translationally relevant targets, integrating precision medicine and biomarker-driven patient selection, and employing advanced translational models and innovative technologies.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。